| Reviewed By |
| |
Donald Farquhar
, MD, FRCPC
|
| |
David R. Dixon
, MD, MCISc (FM), CCFP
|
| |
National Education Committee, The University of Western Ontario
|
| |
| Prepared By |
| |
Jennifer Blake
, MD, MSc
|
| Reviewed By |
| |
Vivien Brown
, MDCM, CCFP, FCFP
|
| |
Michael Boivin
, B.Sc.Phm.
|
| |
Joan Bratty
, MD
|
| |
Dianne Delva
, MD, FCFP
|
| |
John Rowen
, MD
|
| |
Catherine Wilkie
, BSc, MD, CCFP, FCFP
|
| |
Wendy McCrady
, BScN, MScN , RN(EC)/NP
|
| |
| Prepared By |
| |
Sheldon Spier
, MD, FRCP(C)
|
| Reviewed By |
| |
Paolo Renzi
, MD, FRCPC
|
| |
Alan Kaplan
, MD
|
| |
Jacques Bouchard
, MD
|
| |
Robert Hauptman
, MD
|
| |
Gordon Dyck
, MD
|
| |
Robert Woodland
, MD
|
| |
| Reviewed By |
| |
R.G. Josse
, MD, FRCPC
|
| |
Shawn Davison
, PhD
|
| |
Angela Cheung
, MD, PhD, FRCPC, CCD
|
| |
Christopher Kovacs
, MD, FRCPC, FACP
|
| |
Elizabeth Shane
, MD
|
| |
Aliya Khan
, MD, FRCPC, FACP, FACE
|
| |
Rick Adachi
, MD, FRCPC
|
| |
| Prepared By |
| |
Alan Ableson
, MD, CCFP, FCFP
|
| |
John Axler
, MD, CCFP
|
| |
| Prepared By |
| |
Lorne Gula
|
| Reviewed By |
| |
Evan Lockwood
|
| |
Martin J. Gardiner
|
| |
Laurent Macle
|
| |
| Reviewed By |
| |
François Boucher
, MD, FRCPC
|
| |
James Kellner
, MD
|
| |
Nandini Sathi
, MD, CCFP
|
| |
Phyllis Bedder
, MD
|
| |
Lydia Hatcher
, MD, CCFP, FCFP
|
| |
Carol McConnery
, MD
|
| |
Bruce H. Wheeler
, MD, CCFP
|
| |
| Reviewed By |
| |
Serge Marchand
, PhD
|
| |
| Reviewed By |
| |
Anjli Acharya
, B.Sc.Phm., R.Ph., CTH
|
| |
Milena Kudus
, B.Sc.Phm., R.Ph., CTH
|
| |
Stephanie Young
, RN
|
| |
|
Asthma Virtual PracticeLearning Objectives:- Understand the impact of asthma and the results of poor asthma control on a patient’s quality of life
- Discuss established and new approaches to managing your asthma patients, including the risks and benefits of various treatment approaches
- Understand the role and importance of asthma education and an up-to-date asthma action plan in a patient’s asthma control
- Apply the concepts learned to better counsel patients on their asthma and achieving better control of their disease
SOGC Menopause and Osteoporosis Update 2009 - Vasomotor Symptoms (En Francais)Learning Objectives- Provide reassurance to patients that vasomotor symptoms are common, troubling, treatable symptoms associated with menopause;
- Present nonpharmacologic and pharmacologic options to patients suffering vasomotor symptoms;
- Counsel patients and dispel myths about the benefits and risks of hormonal therapy using evidence-based medicine; and
- Counsel patients about the use of "natural" and herbal products.
Optimizing Care in Paediatric Asthma(En Francais)Learning Objectives
- Diagnose paediatric asthma based on asthma phenotype.
- Discuss common asthma triggers and avoidance strategies in the management of your paediatric asthma patients.
- Apply Canadian paediatric guideline based treatment strategies for your paediatric asthma patients.
- Address common parent concerns regarding the treatment of asthma including adherence and adverse effects.
- Work with your patients and their parents to develop an asthma management strategy.
St. Michael’s Hospital Osteoporosis Outreach Program 2009Learning Objective:
Our goal is to provide up-to-date, evidence-based, scientifically sound, useful and practical information for specialists on different aspects of metabolic bone disease focusing on osteoporosis. Each individual presentation has established learning objectives.
Occupational and Environmental Cancer: Recognition and PreventionLearning Objectives
- Name common types of occupational and environmental cancer.
- Describe how carcinogens are identified.
- Find and use published lists of carcinogens.
- Take and interpret an exposure history.
- Identify steps to take if an occupational or environmental cancer is suspected or your patient is being exposed to a carcinogen.
- Assess a cancer cluster report.
- Apply the recognition process to other occupational and environmental diseases.
A Fib and the ATHENA Trial - an Appraisal(En Francais)- Identify the attributes of good quality clinical trials
- Critically appraise, using an appraisal tool, the ATHENA study:
[Hohnloser SH, Crijns HJGM, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ, for the ATHENA Investigators. Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation. N Engl J Med 2009;360(7):668-678.] - Discuss the strengths and weaknesses of the ATHENA trial
Pneumococcal Virtual Practice UpdatedLearning Objectives:- Understand risks of acute and long term complications of pneumococcal infections
- Be able to explain the benefits and possible adverse events of pneumococcal vaccines.
- Understand what underlying conditions increase the risk of pneumococcal infections.
- Understand patient concerns about vaccination and their limited preoccupation regarding the disease.
- Apply the concepts learned to better counsel patients on available options for preventing pneumococcal infection.
Diffuse Pain in Fibromyalgia: From Neurophysiology to Clinical ObservationLearning Objectives
Patients suffering from fibromyalgia present diffuse pain symptoms that are not characteristic of neurogenic pain. However, some neurophysiological mechanisms, such as a disturbance of endogenous pain modulation systems may help understanding the mechanisms implicated. During this talk I will introduce some our work on different factors that are affecting the efficacy of these endogenous pain modulation mechanisms and discuss how diffuse pain may result from a central imbalance in endogenous excitatory and inhibitory mechanisms. Recent data will be presented supporting our understanding of the neurophysiological mechanisms of diffuse pain in fibromyalgia with some references to the clinical signs observed in the fibromyalgia patients.
Travel Medicines- A Focus on Malaria and Hepatitis A and B(En Francais)Learning Objectives - The basic risk factors, etiology, and clinical presentation of hepatitis A, hepatitis B and malaria.
- The geographical risk areas for hepatitis A, hepatitis B, and malaria, including areas of antimalarial drug resistance.
- Personal protective measures important for the prevention of hepatitis A, hepatitis B and malaria.
- Key considerations when vaccinating against hepatitis A and hepatitis B and how to manage non-responders.
- Key differences between available anti-malarial agents, their adverse effects, contraindications, and costs.
- Key considerations in special populations including pregnant or lactating women, children, immune compromised patients, and non-compliant patients.
|